Janssen Biotech, Inc. v. Accord BioPharma, Inc. - 1:26-cv-00222

Janssen Biotech, Inc. v. Accord BioPharma, Inc. (Case No. 1:26-cv-00222), filed on Mar 3, 2026 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:26-cv-00222
Filing Date
Mar 3, 2026
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Janssen Biotech, Inc. -
Accord BioPharma, Inc. -
Bio-Thera Solutions, Ltd. -

Patents Involved

This case involves 17 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Mar 4, 2026Summons Issued as to Accord BioPharma, Inc. on 3/4/2026; Bio-Thera Solutions, Ltd. on 3/4/2026. (Attachments: # 1 Summons Issued)(scs) (Entered: 03/04/2026)PACER Document
Mar 3, 2026Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Biotech, Inc. and Janssen Sciences Ireland UC, filed by Janssen Biotech, Inc., Janssen Sciences Ireland UC. (scs (Entered: 03/04/2026)PACER Document
Mar 3, 2026Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,017,325; 8,586,356; 8,852,889; 8,956,830 ; 9,170,249; 9,217,168 ; 9,475,858; 9,487,810; 9,663,810; 9,890,410; 11,014,982; 11,041,020; 12,122,824; 12,129,292; 12,139,735; 12,180,271; 12,291,566. (Attachments: # 1 Patent/Trademark Report 2, # 2 Patent/Trademark Report 3, # 3 Patent/Trademark Report 4)(scs) (Entered: 03/04/2026)PACER Document
Mar 3, 2026EXHIBITS B-R in Support of 2 Complaint - by Janssen Biotech, Inc., Janssen Sciences Ireland UC. (Attachments: # 1 Exhibit L-M, # 2 Exhibit N-R)(scs) (Entered: 03/04/2026)PACER Document
Mar 3, 2026Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 03/04/2026)PACER Document
Mar 3, 2026[SEALED] COMPLAINT for Patent Infringement against Accord BioPharma, Inc., Bio-Thera Solutions, Ltd. (Filing fee $ 405, receipt number ADEDC-4913694) - filed by Janssen Sciences Ireland UC, Janssen Biotech, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(scs) (Entered: 03/04/2026)PACER Document
Mar 3, 2026MOTION for Leave to File Complaint and Exhibit Under Seal - filed by Janssen Biotech, Inc., Janssen Sciences Ireland UC. (Attachments: # 1 Text of Proposed Order)(scs) (Entered: 03/04/2026)PACER Document
Mar 4, 2026ORDER Granting 1 MOTION for Leave to File Complaint and Exhibit Under Seal. Redacted versions shall be filed within seven (7) days of this Order. Signed by Judge Richard G. Andrews on 3/4/2026. (aas) (Entered: 03/04/2026)PACER Document
Mar 4, 2026SUMMONS Returned Executed by Janssen Sciences Ireland UC, Janssen Biotech, Inc..Accord BioPharma, Inc. served on 3/4/2026, answer due 3/25/2026. (Joyce, Alexandra) (Entered: 03/04/2026)PACER Document
Mar 4, 2026Remark: Case submitted for routine judicial assignment. (scs)PACER Document